REGENXBIO Inc. (RGNX) Net Income (Loss) Attributable to Parent USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
REGENXBIO Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2024.
  • REGENXBIO Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$63.3 M, a 5.02% increase year-over-year.
  • REGENXBIO Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$260 M, a 3.75% increase year-over-year.
  • REGENXBIO Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$263 M, a 6% increase from 2022.
  • REGENXBIO Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$280 M, a 319% decline from 2021.
  • REGENXBIO Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $128 M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$260 M -$63.3 M +$3.35 M +5.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$263 M -$62.9 M -$2.95 M -4.93% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$261 M -$61.9 M +$13.6 M +18% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$274 M -$72.1 M -$3.88 M -5.69% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$270 M -$66.7 M +$10 M +13.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$280 M -$59.9 M -$354 M -120% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $73.6 M -$75.5 M -$17.1 M -29.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $90.7 M -$68.2 M -$10.5 M -18.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $101 M -$76.7 M -$26.6 M -53% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $128 M $294 M +$340 M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$212 M -$58.4 M -$67.2 M -764% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$145 M -$57.6 M -$23.9 M -70.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$121 M -$50.1 M -$10.1 M -25.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$111 M -$46.2 M -$19.8 M -74.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$91.5 M $8.79 M +$43.4 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$135 M -$33.8 M -$32.3 M -2217% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$103 M -$40 M -$7.81 M -24.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$94.7 M -$26.5 M -$30.8 M -715% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$64 M -$34.6 M -$15.4 M -80.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$48.6 M -$1.46 M -$12.1 M -114% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$36.5 M -$32.2 M -$136 M -131% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 $99.9 M $4.31 M +$20.3 M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 $79.6 M -$19.2 M +$1.5 M +7.26% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 $78.1 M $10.6 M +$25.1 M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 $53.1 M $104 M +$126 M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$73.2 M -$16 M +$3.61 M +18.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$76.8 M -$20.7 M -$2.55 M -14.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$74.2 M -$14.5 M -$36 K -0.25% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$74.2 M -$22 M -$11.2 M -104% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$63 M -$19.6 M -$14.4 M -279% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$48.5 M -$18.2 M -$10.8 M -148% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$37.7 M -$14.4 M -$8.15 M -130% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$29.6 M -$10.8 M -$6.76 M -168% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 -$22.8 M -$5.18 M -$2.85 M -122% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-07
Q3 2015 -$20 M -$7.33 M -$5.54 M -309% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-07
Q2 2015 -$14.4 M -$6.29 M -$5.62 M -836% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-07
Q1 2015 -$8.81 M -$4.01 M -$4.81 M -605% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-07
Q4 2014 -$4 M -$2.33 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-03
Q3 2014 -$1.79 M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-03
Q2 2014 -$672 K Apr 1, 2014 Jun 30, 2014 10-K 2016-03-03
Q1 2014 $795 K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.